Dr Cutler, who leaves Quintiles after 14 years in the oncology and global project management office, replaces Chris Bergen who becomes Cincinnati-based Kendle’s new chief administrative officer (CAO).
In a press release Cutler said that: “The long-term outlook for clinical development outsourcing remains strong, and I am committed to furthering Kendle's focus on operational excellence and strategic customer relationships across the Phase II-IV market."
Prior to joining the contract research organisation (CRO) Quintiles Cutler worked for Sandoz, now owned by Swiss drug major Novartis, in Australia and Europe where he served as a Group Head providing leadership for Phase I-III trials in a number of therapeutic areas.